Even the best possible response to medication is unlikely to produce enough weight loss, he says
27 JassamY
Starting at a lower initial dose (for example, 2 mg instead of 4 mg) also helped partially reduce these GI symptoms, andas with other GLP-1 medicationsthe dose was gradually increased over time to improve tolerability
Dry, sticky or overly dense products can quickly become unappealing, leading to rejection of foods and beverages, including familiar favorites. GLP-1 consumers have unmet needs, often finding themselves skipping meals and experiencing downstream health effects like muscle loss and fatigue . IFF Conventional diet talk falls flat with GLP-1 users Similarly, messaging that has traditionally been designed to appeal to people watching their weight doesnt resonate at all with GLP-1 users, who dont need to be told to control cravings, watch calories, or select guilt-free options, notes IFF
Other amylin-based molecules which are in early stage clinical trials include long-acting amylin agonists and a dual amylin and calcitonin RA (Table 1)
Leveraging the proven efficacy of current treatments with these new pathways may prove to be a lucrative value offering for manufacturers looking to stand out